'Gliptin' use in type 2 diabetes may increase risk of developing inflammatory bowel diseaseStudy authors suggest avoiding DPP-4 inhibitors in patients with a family history of inflammatory bowel disease and monitoring for persistent gastrointestinal symptoms Educational efforts reduce docusate use in hospitalized patientsAlberta pharmacists reduce use of stool softener that has limited efficacy in preventing constipation Current management recommendations for Helicobacter pylori infections in adults Proton pump inhibitors linked to increased mortality May be time to restrict use of the drugs, say researchers Updated guidelines on dyspepsia management US/Canadian guidelines clarify tests for diagnosis and sequence of therapies New Canadian consensus guidelines on use of capsule endoscopy Recommendations focus on use in Crohn’s disease, celiac disease and GI bleeding Colostomies and ileostomies: Key considerations for medication use in ostomy patients Guideline recommends when and how to stop prescribing proton pump inhibitors An approach to stopping a PPI, stepping down therapy or reducing PPI doses Long-term antibiotics linked to colorectal polyps Findings add to emerging evidence that gut bacteria may have key role in cancer development Colorectal cancer becoming more common in younger patients Screening guidelines may need to be revisited, researchers suggest First Previous 14 15 16 17 18 Next Last
